Home/Filings/4/0001140361-20-025729
4//SEC Filing

Zaremba Rabourn Amy 4

Accession 0001140361-20-025729

CIK 0001228627other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:31 PM ET

Size

5.2 KB

Accession

0001140361-20-025729

Insider Transaction Report

Form 4
Period: 2020-11-11
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-11-11+75,00075,000 total
    Exercise: $4.05Exp: 2030-11-11Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]1,562 shares vest each month-end from November 2020 through October 2024.

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001832343

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:31 PM ET
Size
5.2 KB